Motor fluctuations and dyskinesia are common complications of long-term lev
odopa therapy. The neural and molecular mechanisms underlying their develop
ment are partially understood. A variety of clinical strategies may reduce
the unpredictability of motor fluctuations and reduce their impact. Prevent
ion of these complications remains an elusive goal. (C) 2001 Published by E
lsevier Science Ltd.